CD4 and tuberculosis: We found that CTX use at CD4 ≤ 50 cells/μL was associated with reduced hazard for TB compared to those not receiving CTX within the same CD4 ≤ 50 cells/μL category: HR = 0.37, 95% CI (0.21 to 0.65), p < 0.001.